WEGO Medical is pleased to invite global partners and industry professionals to visit us at the China International Medical Equipment Fair 2026, one of the
WGDSA-150-MA
DSA-150-MA Syringe
WEGO Sterile High Pressure Angiographic Syringes for Single Use are designed specifically for interventional vascular procedures.
This single-use high-pressure angiographic syringe features high pressure performance and rigorous sterile processing to ensure safety and effectiveness during cardiovascular treatments.
Overview
Sterile High Pressure Angiographic Syringes for Single Use is intended to be used inconjunction with a variety of high-pressure injection equipment for Digital SubtractionAngiography (DSA), Computed Tomography (CT)and Magnetic Resonance Imaging (MRl)examinations, operated by professional medical staff, and the injection of contrast agents into the patients.
Noted
The product should be used by trained and qualified professionals. Any operation of thisproduct by unauthorized or untrained person will not be permitted
specification
Specification
| Machine Model | Medrad Mark V |
| Highest pressure limit | 1200psi |
| Accessories | CT Connecting Tube/ |
Intended Purpose
| Sterile High Pressure Angiographic Syringes for Single Use is intended to be used inconjunction with a variety of high-pressure injection equipment for Digital SubtractionAngiography (DSA), Computed Tomography (CT)and Magnetic Resonance Imaging (MRl)examinations, operated by professional medical staff, and the injection of contrast agents into the patients. |
Intended patient population & Patient selection criteria
| The intended users of the device are patients who need to inject contrast agents. Theexpected patient population includes adults |
Medical condition
| Sterile High Pressure Angiographic Syringes for Single Use is applicable for use inprofessional healthcare facility environment. |
Documents
certificate
News
Read More »
Abstract The study published in “Zhejiang Journal of Traumatic Surgery” investigates the role of transpedicular grafting of injectable artificial bone in promoting healing of fractured vertebrae
WEGO Medical will participate in the 12th AfSBT International Congress, scheduled to be held from 23–26 March 2026 in Windhoek, Namibia. AfSBT is an important
WEGO Medical, a subsidiary of Weigao Group, is a leading medical device manufacturer。WEGO Medical, a subsidiary of Weigao Group
Related accessories
